HNN3.0
Register
Register
Register

Project cooperationUpdated on 24 January 2026

3D Tissue Engineering and Fabrication Frameworks for Human-Relevant Biomedical Platforms

Research Manager at Institute for Bioengineering and Biosciences

Lisboa, Portugal

About

What we aim to do

Support the development, standardisation and uptake of advanced human-relevant biomedical platforms by aligning 3D tissue engineering, biomaterials and biophysical stimulation with reproducible fabrication protocols.

What we can contribute

  1. Advanced 3D tissue fabrication, including bioprinting, bio-inks and biomaterial-based scaffolds enabling controlled and reproducible cellular microenvironments

  2. Material and biophysical engineering (electrical, mechanical, magnetic cues) to create physiologically relevant and tunable tissue contexts

  3. Design of bioreactors and fabrication workflows supporting robustness, comparability and cross-site implementation of complex 3D tissue systems

  4. Contribution to best practices, reference protocols and quality attributes for advanced 3D human tissue platforms used in biomedical research and translation

Partners we are looking for

Research infrastructures, technology developers, standardisation and regulatory-oriented groups, and academic or industrial users of advanced 3D human tissue platforms.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Organisation

Institute for Bioengineering and Biosciences

R&D Institution

Lisboa, Portugal

Similar opportunities

  • Project cooperation

    Patient-Derived iPSC & 3D Human Tissue NAM Platforms

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Sofia Aires Martins

    Research Manager at Institute for Bioengineering and Biosciences

    Lisboa, Portugal

  • Project cooperation

    Looking for Consortium

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Oscar Castano

    Tenured Associate Professor at Universitat de Barcelona

    Barcelona, Spain

  • Project cooperation

    Bioprocessing and Quality-by-Design Platforms for Cell-, Gene- and EV-Based ATMPs

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

    Sofia Aires Martins

    Research Manager at Institute for Bioengineering and Biosciences

    Lisboa, Portugal